Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Bendamustine Hydrochloride Injection, Solution in shortage?

Bendamustine Hydrochloride Injection, Solution is listed by FDA as being discontinued by at least one maker (updated Jul 23, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)
    Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)Being discontinuedUpdated Jul 23, 2026Discontinued Jul 23, 2026

    A business decision has been made to discontinue manufacture of the drug.

    Maker contact: (610) 344-0200

Bendamustine Hydrochloride Injection, Solution shortage questions

Is Bendamustine Hydrochloride Injection, Solution in shortage?

Bendamustine Hydrochloride Injection, Solution is listed by FDA as being discontinued by at least one maker (updated Jul 23, 2026).

What should I do if I can’t get Bendamustine Hydrochloride Injection, Solution?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.